This lawsuit underscores the SEC’s ongoing efforts to combat fraudulent practices in the stock market and protect unsuspecting investors. BioVie Inc., which is not accused of wrongdoing, continues to operate as a clinical-stage pharmaceutical company.
- America
- And More
- Business
- California News
- International
- Investigates
- New York News
- The People's Voice
- U.S. News
- USA Herald
